Listen "Cannabinoid Use in Pediatrics, Part 1: What is CBD?"
Episode Synopsis
Although marijuana and its derivatives are currently Schedule 1 substances per the federal Controlled Substances Act (CSA), many states have relaxed their legislation to allow use. In this 3 part series on Cannabinoid Use in Pediatrics, Jennifer Griffith, MD, PhD discusses how more recently, the use of cannabidiol (CBD) products in pediatrics has sparked additional debate, and pediatric providers have started encountering patients experimenting with these products in their daily practice, necessitating an understanding of the history and available medical literature on this topic.
More episodes of the podcast Radio Rounds
Clubfoot: Diagnosis, Treatment and Outcomes
09/03/2021
New Clinic Cares for MIS-C Patients
13/01/2021
Pediatric Toxicology and Lead Clinic
05/01/2021
Helpful Apps for Busy Physicians
29/12/2020
Pediatric Heart Center Telemedicine Program
19/12/2020
After Hours Convenient Care: COVID Update
01/10/2020
Specialized Care for Severe Asthma
22/09/2020